Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pfizer Ltd. Regulatory Filings 2021

Apr 7, 2021

60507_rns_2021-04-07_a6a9efef-3032-4ad9-a268-7a9655ff7297.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

Pfizer Limited

==> picture [94 x 39] intentionally omitted <==

The Capital, 1802/1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

April 7, 2021

The Corporate Relationship Dept. The Manager, Listing Dept. BSE Limited The National Stock Exchange of India Ltd. 1[st] Floor, P.J.Towers Exchange Plaza, 5[th] Floor, Dalal Street, Fort Plot No. C/1, G Block Mumbai - 400 001 Bandra-Kurla Complex, Bandra (E) Scrip Code: 500680 Mumbai - 400 051 Scrip Symbol: PFIZER

Dear Sirs,

Sub: Pfizer Limited - Non-Applicability of Initial/Annual Disclosure to be made by an

entity identified as a Large Corporate.

I, Prajeet Nair, Company Secretary of Pfizer Limited (“Company”) hereby confirm that, the Company has no borrowings as on March 31, 2021 and does not fall under the category of Large Corporate as per the SEBI circular dated November 26, 2018 bearing number SEBI/HO/DDHS/CIR/P/2018/144. Accordingly, the requirement for submission of Initial / Annual disclosure under the said Circular is not applicable to the Company

We request you to kindly take the same on record.

Thanking you,

Yours truly,

For Pfizer Limited

==> picture [105 x 52] intentionally omitted <==

Prajeet Nair Company Secretary

CIN: L24231MH1950PLC008311 Email ID: [email protected] Website: www.pfizerindia.com